Qualigen Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
QLGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
2042 Corte Del Nogal, Carlsbad, California, CA

There are no Buy or Sell transactions made by insiders since 12/24/2023

Qualigen Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Graydon Bensler Director Nov 7, 2024
Cody Price Director Jul 12, 2024
Campbell Becher Director Jul 12, 2024
Robert Bradley Lim Director Jul 12, 2024
Braeden Lichti Director Oct 8, 2024
Sidney W. Emery Jr Director Jul 11, 2022
Kurt H. Kruger Director Jul 11, 2022
Tariq Arshad SVP/Chief Medical Officer Jul 11, 2022
Amy S. Broidrick President/CSO, Director Jul 11, 2022
Michael S. Poirier Chairman and CEO, Director Jul 11, 2022
Christopher L. Lotz Vice President of Finance, CFO Jul 11, 2022
Shishir K. Sinha VP, COO & Secretary Jul 11, 2022
Matthew E. Korenberg Director Jul 11, 2022
Richard A. David Director Jul 11, 2022
Wajdi Abdul-Ahad Vice President, R & D, CSO Jul 11, 2022
Ira E. Ritter Director Jul 11, 2022

Recent Insider Transactions by Companies or Individuals for Qualigen Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.